Research and Treatment

Research & Treatment

Advances in treatment have made it possible for people with hemophilia to lead relatively normal lives, but Glenn Pierce has...
Gordon Vehar was happily headed toward a career as a science teacher when something happened in his senior year of...
Danielle Nance was in fifth grade when she decided to become a physician. A bookshelf in her classroom was filled...
When the Pfizer-BioNTech and Moderna COVID-19 vaccines became publicly available in December 2020, healthcare professionals around the country called them...
When you have a bleeding disorder, staying on top of treatment regimens can prevent devastating consequences. Adherence is associated with...
Jordan Shavit, MD, PhD, pays forward the support he’s received from NHF.
After decades of research, gene therapy for hemophilia is here—but questions remain.
From academia to industry to advocacy, the National Hemophilia Foundation’s new president and CEO, Leonard Valentino, MD, has done it...
Telemedicine can bridge the distance between doctor and patients.
Last September, scientists, doctors, advocates and people with hemophilia gathered in Washington, DC, for the National Hemophilia Foundation’s (NHF) 15th...
In May 2018, more than 200 people representing scientific researchers, hemophilia patients, advocates, clinicians and the pharmaceutical industry gathered in...
Welcoming a new NHF-Shire clinical fellow.
Chat Icon
Need Info? Ask NHF!
Contact HANDI, NHF's resource center for additional information on bleeding disorders.